Skip to Main Content

Issue Areas

  • Education Clearing pathways to a meaningful education
  • Environment Building solutions at the intersection of climate innovation and environmental justice
  • Health Accelerating cancer research and empowering patients
  • Immigration Helping aspiring Americans and new immigrants succeed
  • Media & Journalism Provoking thought and strengthening democracy
  • Equity & Justice Elevating leaders and models at the forefront of change
  • Bloomhouse Co-creating a thriving East Palo Alto with the community
  • Chicago CRED Creating real economic destiny in Chicago
  • E Pluribus Unum Building a more just, equitable, and inclusive South
  • XQ: The Super School Project Rethinking America's high schools

About Emerson

  • About Us A letter from Laurene Powell Jobs
  • Our Team Meet the members of the Collective
  • Our Fellowships Amplifying extraordinary voices
  • Careers Join the Collective

Share this page

  • facebook
  • twitter
  • linkedin

Everyone Counts: How Opening Cancer Research to Patients Leads to Better Outcomes

Health

Posted March 2019

By involving cancer patients in research-collecting efforts, Count Me In can speed the discovery and development of new treatments.


African American women under the age of 45 develop metastatic breast cancer at higher rates than do white women, and have higher mortality rates than any other group. And yet prevention and treatment efforts tend not to focus on them, nor other subsets, like men, some 2,600 of whom are expected to be diagnosed with breast cancer in 2019. A big part of that has to do with the ways these diseases are studied. Because research is typically limited to patients at a few large urban hospitals, huge swaths of the country are not counted in scientific surveys, which leads to incomplete data on patient outcomes and missed opportunities for insights.

Count Me In is a nationwide nonprofit organization that brings patients, doctors, and clinicians together to fill that gap. By inviting patients to share genetic samples and medical record information with leading research organizations, Count Me In is empowering patients—particularly those who are the least visible—to be active participants in the efforts that will lead to breakthrough discoveries and treatment.

Connected Stories

  • Emerson Collective and Takeda Launch Oncology Innovation Accelerator Initiative: Advancing Oncology Therapeutics Through Creative Collaboration Focused on Research and Translational Science

    Innovative alliance of stakeholders aligns industry expertise and support offering academic investigators a new approach to accelerate patient-driven oncology research

    Health
  • Undocumented and Uninsured

    Healthcare in the United States has largely been treated as a privilege reserved for citizens who could afford it; in most states, undocumented immigrants are unilaterally excluded. But individual exclusion has a collective cost.

    Health, and Immigration
  • The American Cancer Society and Emerson Collective Launch Grants to Encourage Collaborative Online Research

    Grants will support interdisciplinary teams who participate in the ACS’s online platform.

    Health

From Our Network

  • Demo Day '19: Max Krummel

    Professor Krummel is a champion of collaborative science; his ImmunoX Initiative promotes data sharing and joint research across fields, disciplines, demographics, and geographies.

    Health

Stay Informed

Join our mailing list and follow us on social.

Email address is not valid. Email addresses should follow the format user@domain.com and must originate from a valid domain.

You may unsubscribe at any time. By submitting information, you accept our Privacy Policy.

  • facebook
  • twitter
  • instagram
  • linkedin

Copyright © 2022 Emerson Collective

  • Terms and Conditions
  • Privacy Policy
  • Unsolicited Submission Policy
  • Fraudulent Requests